posted by on Aug 29
Fen-phen Progression Claim
Diet drug Fen-Phen, or fenfluramine, was banned in the United States in 1997. A Fen-Phen class action lawsuit was filed and won by plaintiffs, and now the Fen-Phen progression claim is entering its final phase. For those who are unfamiliar with the term “progression claim”, it’s for:
- people who registered for the claim in a timely manner
- those who used Fen-Phen
- people whose conditions have progressed to a point where they may need extra compensation
To become part of the Fen-Phen progression claim, it’s extremely important to pay attention to deadlines, since they tend to be very strict for these types of claims.
Fen-Phen was popular in the 1990s, and approved by the FDA in 1996, even though the chief medical officer refused to sign the approval. Another FDA officer approved the drug, just a year before studies showed that women taking the drug developed . Dr. Heidi Connelly of the Mayo Clinic, reporting in The New England Journal of Medicine in August 1997, linked her patients taking Fen-Phen with pulmonary hypertension and heart-valve abnormalities. Fen-Phen was banned: Pondimin and Redux, brand names for Fen-Phen, produced by American Home Products were recalled from the shelves.
Fen-Phen cost American Home Products $3.75 Billion in the end, and Fen-Phen progression claims continue to this day.